Description
Arixtra 2.5 mg / 0.5 ml contains fondaparinux sodium, a prescription anticoagulant (blood thinner) used to help prevent or treat certain blood clotting conditions under medical supervision. It works by selectively inhibiting Factor Xa, helping reduce the formation of harmful blood clots and preventing clot progression.
It comes in pre-filled syringes for subcutaneous injection, providing convenient fixed-dose administration. It is commonly used for prevention of deep vein thrombosis (DVT), pulmonary embolism (PE), and selected clot-related conditions depending on clinical assessment.
Key Benefits
- Contains Fondaparinux 2.5 mg / 0.5 ml
- Prescription anticoagulant therapy
- Helps prevent blood clot formation
- Pre-filled syringes for convenient administration
- Fixed accurate dosing
- Pack of 10 syringes
How to Use
- Use exactly as prescribed by a physician
- Administer by subcutaneous injection only unless otherwise instructed
- Follow prescribed treatment duration carefully
- Do not change dose or discontinue without medical advice
Indications
- Prevention of deep vein thrombosis (DVT)
- Prevention or management of pulmonary embolism (PE)
- Post-surgical clot prevention
- Selected thromboembolic conditions under physician supervision
Warnings
- May increase bleeding risk
- Do not use with active major bleeding
- Use cautiously in renal impairment
- Drug interactions may increase bleeding risk
- Inform physician before surgery or invasive procedures
- Pregnancy/breastfeeding requires medical supervision
- Prescription-only medicine
Possible Side Effects
- Bleeding or bruising
- Injection site pain or irritation
- Anemia
- Nausea
- Headache
- Rash or allergic reactions
Product Details
- Form Pre-filled syringes
- Strength 2.5 mg / 0.5 ml
- Pack Size 10 syringes
- Active Ingredient Fondaparinux Sodium
- Category Anticoagulant / Blood thinner
- Administration Route Subcutaneous injection